Brett A. Wall - Jun 18, 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Pres Neuroscience
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Jun 18, 2021
Transactions value $
-$42,379
Form type
4
Date filed
6/22/2021, 05:58 PM
Previous filing
Jun 2, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $87.4K +1.17K +5.44% $74.84 22.7K Jun 18, 2021 Direct F1
transaction MDT Ordinary Shares Tax liability -$116K -938 -4.14% $123.23 21.7K Jun 18, 2021 Direct F1
transaction MDT Ordinary Shares Sale -$14.2K -115 -0.53% $123.50 21.6K Jun 21, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1.17K -14.57% $0.00 6.85K Jun 18, 2021 Ordinary Shares 1.17K $74.84 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.